155 related articles for article (PubMed ID: 9830966)
21. Atorvastatin and portal pressure.
Zamora-Valdés D; Uribe M; Méndez-Sánchez N
Hepatology; 2007 Oct; 46(4):1309-10; author reply 1310. PubMed ID: 17894304
[No Abstract] [Full Text] [Related]
22. Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench.
Shimada K; Miyauchi K; Daida H
Circulation; 2004 May; 109(18):e213-4; author reply e213-4. PubMed ID: 15136515
[No Abstract] [Full Text] [Related]
23. [Endothelial dysfunction, inflammation and statins: new evidences].
Tuñón J; Egido J
Rev Esp Cardiol; 2004 Oct; 57(10):903-5. PubMed ID: 15469785
[No Abstract] [Full Text] [Related]
24. Atorvastatin: in the management of hyperlipidaemia.
Ray SK; Rege NN
J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482
[No Abstract] [Full Text] [Related]
25. Atorvastatin: a new agent for hyperlipidemia.
Kupecz D
Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
[No Abstract] [Full Text] [Related]
26. [Atorvastatin dreduces sympathetic activity and improves baroreceptor reflex sensitivity in patients with hypercholesterolemia and hypertension].
Raczak G
Kardiol Pol; 2009 Jun; 67(6):621-2. PubMed ID: 19852090
[No Abstract] [Full Text] [Related]
27. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
Isaacsohn JL; Davidson MH; Hunninghake D; Singer R; McLain R; Black DM
Am J Cardiol; 2000 Jul; 86(2):250-2. PubMed ID: 10913499
[No Abstract] [Full Text] [Related]
28. Atorvastatin and glatiramer acetate: new hope in MS?
Bradbury J
Lancet Neurol; 2006 May; 5(5):386-7. PubMed ID: 16639832
[No Abstract] [Full Text] [Related]
29. Effect of atorvastatin on plasma fibrinogen.
Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
Lancet; 1998 Feb; 351(9102):569-70. PubMed ID: 9492781
[No Abstract] [Full Text] [Related]
30. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study.
Galin ID; Smith DA
Am Heart J; 2006 May; 151(5):e1. PubMed ID: 16644302
[No Abstract] [Full Text] [Related]
31. [Fluvastatin in a comparative study. Are there substance-specific differences between various CSE-inhibitors?].
Internist (Berl); 1999 Mar; 40(3 Suppl Gibt Es):1-4. PubMed ID: 10192028
[No Abstract] [Full Text] [Related]
32. The nature of the statins.
Jones PH
Circulation; 2000 Feb; 101(8):E89. PubMed ID: 10694539
[No Abstract] [Full Text] [Related]
33. Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia.
Majima T; Komatsu Y; Fukao A; Ninomiya K; Matsumura T; Nakao K
Endocr J; 2007 Feb; 54(1):145-51. PubMed ID: 17185879
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of atorvastatin in the treatment of hypercholesterolemia associated with antiretroviral therapy.
Palacios R; Santos J; González M; Ruiz J; Valdivielso P; Márquez M; González-Santos P
J Acquir Immune Defic Syndr; 2002 Aug; 30(5):536-7. PubMed ID: 12154347
[No Abstract] [Full Text] [Related]
35. Treatment of severe hypercholesterolemia with atorvastatin in congenital analbuminemia.
Del Ben M; Burattin M; Arca M; Ceci F; Violi F; Angelico F
Am J Med; 2004 Nov; 117(10):803-4. PubMed ID: 15541334
[No Abstract] [Full Text] [Related]
36. Efficacy and safety of chunghyul-dan (qingwie-dan) in patients with hypercholesterolemia.
Cho KH; Kang HS; Jung WS; Park SU; Moon SK
Am J Chin Med; 2005; 33(2):241-8. PubMed ID: 15974483
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia.
Ercan E; Tengiz I; Altuglu I; Sekuri C; Aliyev E; Ercan HE; Akin M
Kardiol Pol; 2004 May; 60(5):454-8. PubMed ID: 15247960
[TBL] [Abstract][Full Text] [Related]
38. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
Wamhoff BR; Dixon JL; Sturek M
J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
[TBL] [Abstract][Full Text] [Related]
39. Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy.
Yamada T; Node K; Mine T; Morita T; Kioka H; Tamaki S; Tsukamoto Y; Masuda M; Okuda K; Fukunami M
Am J Med Sci; 2006 Dec; 332(6):361-3. PubMed ID: 17170629
[TBL] [Abstract][Full Text] [Related]
40. Short-term effects of atorvastatin on haemorheologic parameters, platelet aggregation and endothelium dysfunction in patients with hypercholesterolaemia.
Horvath B; Marton Z; Alexy T; Kesmarky G; Toth K; Szapary L
Eur Heart J; 2004 Jan; 25(1):96. PubMed ID: 14683748
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]